BCC - Basal Cell Carcinoma

Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Philogen
PhilogenItaly - Monteriggioni
1 program
1
L19IL2/L19TNFPhase 21 trial
Active Trials
NCT05329792Unknown70Est. Dec 2024
Pulse Biosciences
Pulse BiosciencesCA - Hayward
1 program
CellFX SystemN/A1 trial
Active Trials
NCT04918381Completed30Est. Jul 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilogenL19IL2/L19TNF
Pulse BiosciencesCellFX System

Clinical Trials (2)

Total enrollment: 100 patients across 2 trials

NCT05329792PhilogenL19IL2/L19TNF

L19IL2/L19TNF in Skin Cancer Patients

Start: Mar 2023Est. completion: Dec 202470 patients
Phase 2Unknown

CellFX Treat & Resect Low-Risk BCC Feasibility Study

Start: Jun 2021Est. completion: Jul 202230 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space